Related references
Note: Only part of the references are listed.Targeting immune cells for cancer therapy
Sin Yee Gun et al.
REDOX BIOLOGY (2019)
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Neuro-ophthalmic side effects of molecularly targeted cancer drugs
M. T. Bhatti et al.
EYE (2018)
CHECKPOINT INHIBITOR IMMUNE THERAPY Systemic Indications and Ophthalmic Side Effects
Lauren A. Dalvin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
Laura C. Cappelli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
Omar Abdel-Rahman et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events
Marianne Davies et al.
IMMUNOTARGETS AND THERAPY (2017)
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
Frank Kroschinsky et al.
CRITICAL CARE (2017)
Efficacy, safety, tolerability and price of newly approved drugs in solid tumors
Tristan A. Barnes et al.
CANCER TREATMENT REVIEWS (2017)
Cyclosporine for Dry Eye Associated With Nivolumab: A Case Progressing to Corneal Perforation
Alexander T. Nguyen et al.
CORNEA (2016)
Ocular and orbital side-effects of checkpoint inhibitors: a review article
Joelle Antoun et al.
CURRENT OPINION IN ONCOLOGY (2016)
Strokes and vision: The management of ischemic arterial disease affecting the retina and occipital lobe
Mitchell Lawlor et al.
SURVEY OF OPHTHALMOLOGY (2015)
Co-occurrence of Acute Retinal Artery Occlusion and Acute Ischemic Stroke: Diffusion-Weighted Magnetic Resonance Imaging Study
Junwon Lee et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
RETINAL TOXICITIES OF CANCER THERAPY DRUGS Biologics, Small Molecule Inhibitors, and Chemotherapies
Catherine Y. Liu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs
Saroj Niraula et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
Constantin N. Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients
Ribhi Hazin et al.
CURRENT OPINION IN OPHTHALMOLOGY (2009)
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
T. Sutlu et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Summary of the primer on tumor immunology and the biological therapy of cancer
Yufeng Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
H Noma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Central serous chorioretinopathy associated with anthrax vaccination
BS Foster et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2004)
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
E Jonasch et al.
ONCOLOGIST (2001)
Share Paper
